IP Library Granted Patent US 10,272,246
Granted Patent B2
US 10,272,246 · App. 15/937,729 · Granted Apr 30, 2019

Methods for extravascular renal neuromodulation

Inventors: Mark Deem (Mountain View, CA); Denise Zarins (Saratoga, CA); Douglas Sutton (Pacifica, CA); Hanson Gifford, III (Woodside, CA); Howard R. Levin (Teaneck, NJ); Mark Gelfand (New York, NY); Benjamin J. Clark (Redwood, CA)
Assignee: Medtronic Adrian Luxembourg S.a.r.l
A61N1/36117A61B18/1492A61N1/0551A61N1/32A61N1/327A61N1/36007A61N1/36017A61N1/36128A61N5/00A61B2018/00267A61B2018/00404A61B2018/00434A61B2018/00511A61B2018/00577A61B2018/00613A61B2018/00702A61B2018/00779A61B2018/00791A61B2018/00875A61B2018/00982A61B2018/1435
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,272,246
App. No.
15/937,729
Granted
Apr 30, 2019
Kind
B2
Abstract

Methods and apparatus are provided for renal neuromodulation using a pulsed electric field to effectuate electroporation or electrofusion. It is expected that renal neuromodulation (e.g., denervation) may, among other things, reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease. Embodiments of the present invention are configured for extravascular delivery of pulsed electric fields to achieve such neuromodulation.

Claims (28)

1. A method for extravascular renal neuromodulation, the method comprising:

positioning a plurality of energy delivery elements carried by a catheter at an extra-arterial location within a hypertensive human patient and adjacent to neural fibers innervating a kidney of the patient; and

ablating the neural fibers innervating the kidney via radio frequency (RF) energy from the energy delivery elements,

wherein ablating the neural fibers results in a therapeutically beneficial reduction in blood pressure of the patient.

2. The method of claim 1 , further comprising monitoring a parameter of the energy delivery elements and/or tissue within the patient before and during delivery of RF energy via the energy delivery elements.

3. The method of claim 2 wherein monitoring a parameter comprises monitoring power, temperature, and/or impedance.

4. The method of claim 2 wherein monitoring a parameter comprises monitoring at least one physiological parameter of the patient.

5. The method of claim 4 wherein the monitored physiological parameter comprises plasma renin levels and/or other neurohormones that are indicative of increased sympathetic nervous activity.

6. The method of claim 2 , further comprising varying delivery of the RF energy in response to the monitored parameter.

7. The method of claim 1 wherein ablating the neural fibers innervating the kidney via radio frequency (RF) energy from the energy delivery elements comprises delivering RF energy in a monopolar fashion between one or more of the energy delivery elements and an external ground pad attached to an exterior of the patient.

8. The method of claim 1 wherein ablating the neural fibers innervating the kidney via radio frequency (RF) energy from the energy delivery elements comprises delivering RF energy in a bipolar fashion between two or more of the energy delivery elements.

9. The method of claim 1 wherein each of the energy delivery elements is dynamically assignable.

10. The method of claim 1 wherein positioning a plurality of energy delivery elements carried by a catheter at an extra-arterial location within the patient comprises delivering a distal segment of the catheter within a probe, and wherein the method further comprises at least partially extending the distal segment of the catheter out from the probe before delivering RF energy via the energy delivery elements.

11. The method of claim 1 wherein ablating the neural fibers innervating the kidney via RF energy from the energy delivery elements comprises ablating afferent renal nerves of the patient via the RF energy from the energy delivery elements.

12. The method of claim 1 wherein ablating the neural fibers innervating the kidney via RF energy from the energy delivery elements comprises ablating both afferent and efferent renal nerves of the patient via the RF energy from the energy delivery elements.

13. The method of claim 1 wherein positioning a plurality of energy delivery elements carried by a catheter at an extra-arterial location within the patient comprises positioning the energy delivery elements at or near a renal hilum of the patient.

14. The method of claim 1 wherein positioning a plurality of energy delivery elements carried by a catheter at an extra-arterial location within the patient comprises positioning the energy delivery elements along a renal vein of the patient.

15. The method of claim 1 wherein positioning a plurality of energy delivery elements carried by a catheter at an extra-arterial location comprises delivering the catheter over a guidewire.

16. The method of claim 1 wherein ablating the neural fibers innervating the kidney via RF energy comprises at least partially denervating the kidney of the patient.

17. The method of claim 1 , further comprising removing the catheter from the patient after delivering the RF energy to conclude the procedure.

18. A method, comprising:

percutaneously introducing a plurality of electrodes at a distal region of a catheter to an extra-arterial location within a human patient and adjacent to renal nerves of the patient;

transforming the distal region of the catheter between a low-profile delivery configuration and an expanded treatment configuration; and

at least partially ablating the renal nerves via radio frequency (RF) energy from the plurality of electrodes,

wherein at least partially ablating the renal nerves significantly improves a measurable physiological parameter associated with hypertension of the patient.

19. The method of claim 18 wherein percutaneously introducing a plurality of electrodes at a distal region of a catheter to an extra-arterial location within the patient comprises positioning the plurality of electrodes under visual guidance.

20. The method of claim 18 wherein percutaneously introducing a plurality of electrodes at a distal region of a catheter to an extra-arterial location within the patient comprises positioning the plurality of electrodes under guidance chosen from the group consisting of computed tomographic, radiographic, ultrasonic, angiographic, laparoscopic and combinations thereof.

21. The method of claim 18 , further comprising removing the catheter from the patient after at least partially ablating the renal nerves.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2019
From: DEMARAIS, DENISE; DEEM, MARK; SUTTON, DOUGLAS; GIFFORD, HANSON, III; LEVIN, HOWARD R.; GELFAND, MARK; CLARK, BENJAMIN J.
To: ARDIAN, INC.
Reel/Frame 048169/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2019
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 048169/0348 →
CHANGE OF NAME Recorded Jan 29, 2019
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 048177/0759 →
Continuity (16)
Continuation 15636381 · Jun 28, 2017
Continuation 15254340 · Sep 1, 2016
Continuation 14878898 · Oct 8, 2015
Continuation 14279023 · May 15, 2014
Continuation 13942223 · Jul 15, 2013
Continuation 13361542 · Jan 30, 2012
Division 11189563 · Jul 25, 2005
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 10900199 · Jul 28, 2004
Continuation In Part 10408665 · Apr 8, 2003
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60442970 · Jan 29, 2003
Related Publication 20180311503A1 · Nov 1, 2018